Unilever’s Beauty & Wellbeing division generated €3.5bn, equal to 26% of group turnover in Q3 26. Underlying sales grew 5.7% compared to 5.2% at group level, driven by 3.6% volume and 2.1% price. Reported turnover increased 9.5%, including a 3.2% contribution from acquisitions.
Hair Care accelerated to double-digit growth. Dove, Sunsilk, Clear and K18 all delivered double-digit growth, led by volume. Dove’s performance was driven by premium innovations in serums, masks and scalp care, alongside strong growth in India and the US.
Skin Care grew mid-single digit. Vaseline delivered double-digit growth, with broad-based performance across markets, especially Asia Pacific Africa. Hourglass, Paula’s Choice and Dermalogica also performed well.
Wellbeing declined high-single digit in the quarter, partly because Prime Day shipment timing benefited Q2. Year to date, sales were down 1.0%. Liquid I.V.’s international expansion and continued share gains in mass retail and online were offset by reduced distribution and the entry of private label in club; Nutrafol declined year to date as customer acquisition measures remain at an early stage. Unilever expects sequential improvement in Wellbeing versus Q3.
The Unilever Q3 2026 Trading Statement now expects underlying sales growth of 4% to 6% for 2026, at least 3% underlying volume growth, and around 5% underlying sales growth in H2. It expects modest improvement in underlying operating margin versus 20.0% in 2025.
